CervoMed Inc. (CRVO) Financials
CRVO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 26.0 million | 3.0 million |
| March 31, 2026 | 15.1 million | 4.5 million |
| Dec. 31, 2025 | 23.4 million | 5.2 million |
| Sept. 30, 2025 | 30.6 million | 4.6 million |
CRVO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -6.9 million | 362275 |
| March 31, 2026 | -8.0 million | 349196 |
| Dec. 31, 2025 | -6.6 million | 298735 |
| Sept. 30, 2025 | -6.5 million | 291717 |
CRVO Net Income
No data available :(
CRVO Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 24.9 million | - | - |
| March 31, 2026 | 12.9 million | - | - |
| Dec. 31, 2025 | 20.9 million | - | - |
| Sept. 30, 2025 | 27.3 million | - | - |
CRVO Shares Outstanding
CRVO Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 4.3 million | 2.4 million | - |
| March 31, 2026 | - | 5.1 million | 3.0 million | - |
| Dec. 31, 2025 | - | 5.8 million | 2.5 million | - |
| Sept. 30, 2025 | - | 6.0 million | 2.3 million | - |
CRVO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | - |
| Dec. 31, 2025 | 8726 | - |
| Sept. 30, 2025 | 322569 | - |
CRVO
Price: $2.62
52 week price:
Earnings Per Share: -3.01 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 38.7 million